Back to search results

A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity

Abroad (travel likely)RecruitingPHASE4

Conditions

Diabetes Mellitus, Type 2 · Obesity · Overweight

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • B. J. Medical College & Civil Hospital, Ahmedabad, India

    Study coordinator · 9586974089
    Contact: Principal Investigator (Kartikeya Parmar)

  • V.S. General Hospital, Ahmedabad, India

    Study coordinator · 9426641888
    Contact: Principal Investigator (DHAIWAT SHUKLA)

  • Gujarat Endocrine Center, Ahmedabad, India

    Study coordinator · 9825599450 and 9428044608
    Contact: Principal Investigator (parag Shah)

  • Jawahar Lal Nehru Medical College, Ajmer, India

    Study coordinator · 7737258659
    Contact: Principal Investigator (Sanjeev Maheshwari)

  • Motilal Nehru Medical College Hospital, Allahābād, India

    Study coordinator · 7007590702
    Contact: Principal Investigator (JITENDRA SHUKLA)

  • Lifecare Hospital and Research Centre, Bengaluru, India

    Study coordinator · 9663370338
    Contact: Principal Investigator (Sreenivasa Murthy)

  • AIIMS, Bhubaneshwar, Bhubaneswar, India

    Study coordinator · 7327030798 6370421141
    Contact: Principal Investigator (Debananda Sahoo)

  • Sri Ramachandra MedicaL College & Research Institute, Chennai, India

    Study coordinator · 044-45928916
    Contact: Principal Investigator (Sudagar Singh)

  • Kovai Diabetes Speciality Center and Hospital, Coimbatore, India

    Study coordinator · 9444548713
    Contact: Principal Investigator (Balamurugan Ramanathan)

  • Apollo Excelcare Hospital, Guwahati, India

    Study coordinator · 9085174978
    Contact: Principal Investigator (Manash Baruah)

  • Osmania Medical College & Hospital, Hyderabad, India

    Study coordinator · 9000464657 9652050894
    Contact: Principal Investigator (Rakesh Sahay)

  • Eternal Heart Care Center and Research Institute, Jaipur, India

    Study coordinator · 9982021057
    Contact: Principal Investigator (Jugal Gupta)

  • K care Hospital, Kanpur, India

    Study coordinator · 9557808393
    Contact: Principal Investigator (Amit Gupta)

  • Brij Medical Centre Private Limited, Kanpur, India

    Study coordinator · 8009626511
    Contact: Principal Investigator (brij mohan)

  • ILS Hospitals, Kolkata, India

    Study coordinator · 9831058704
    Contact: Principal Investigator (Ghanshyam Goyal)

  • Government Medical College, Kozhikode, Kozhikode, India

    Study coordinator · 9778730848
    Contact: Principal Investigator (Rojith Balakrishnan)

  • Wockhardt Hospitals, Mumbai, India

    Study coordinator · 8975247275
    Contact: Principal Investigator (Ramen Goel)

  • Shri Krishna Hrudayalaya & Critical Care Centre, Nagpur, India

    Study coordinator · 7020875496
    Contact: Principal Investigator (Mahesh Fulwani)

  • Sahyadri Super Speciality Hospital, Pune, India

    Study coordinator · 9503105354
    Contact: Principal Investigator (Shashank Shah)

  • All India Institute of Medical Sciences, Raipur, India

    Study coordinator · 9408388382
    Contact: Principal Investigator (Sabah Siddiqui)

  • King George Hospital, Andhra Medical College, Visakhapatnam, India

    Study coordinator · 8555976042 7075852341
    Contact: Principal Investigator (Valluri Prasad)
Study leads

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Study Director

    Eli Lilly and Company

View source on ClinicalTrials.gov(opens in a new tab)